Contineum Therapeutics
IPOLife Reconnected.
Public · San Diego, United States · Founded 2020 · $160.0M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- contineum-tx.com
- Total Funding
- $160.0M
- Last Round
- $100.0M Series BJan 2023
- Rounds
- 2
- Type
- Public
About
Contineum Therapeutics is a clinical-stage biopharmaceutical company developing treatments for autoimmune and neurological diseases.
Summary
Contineum Therapeutics is a Biotech company based in San Diego, United States, founded in 2020. It has raised $160.0M in total across 2 rounds, most recently a $100.0M Series B round in Jan 2023. Investors include Goldman Sachs, Leerink Partners and Stifel.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...